DelveInsight Releases Market Analysis on Pressure Ulcer Treatment

Market research firm DelveInsight has released a comprehensive report focusing on the treatment market for pressure ulcers, also known as bedsores. The report covers the period from 2019 to 2032, analyzing market size, epidemiology, and treatment trends across the United States, Japan, and a consortium of five European nations (Germany, France, Italy, Spain, and the UK).

Pressure ulcers are injuries to the skin and underlying tissue caused by prolonged pressure. They typically develop on bony prominences such as the back, shoulders, elbows, and heels. The condition particularly affects individuals with limited mobility, including hospital patients, nursing home residents, and wheelchair users. Other contributing factors include poor nutrition, dehydration, and age-related skin changes.

The report offers an in-depth understanding of current treatment practices and emerging drugs, assessing the market share of individual therapies. It also examines treatment algorithms, market drivers, barriers, and unmet medical needs to identify opportunities within the sector. DelveInsight's analysis includes historical and forecasted epidemiology, detailing diagnosed patient pools and future trends to understand the prevalence of pressure ulcers across the specified regions.

The market assessment evaluates the overall market size and its segmentation by therapy class and type. Key companies identified in the pressure ulcer treatment market include Smith & Nephew, Integra Life Sciences, Hill-Rom Holdings Inc., Molnlycke Health Care AB, Cardinal Health, Essity Aktiebolag, 3M Company, and B. Braun Melsungen AG. The study aims to equip healthcare professionals and businesses with a clearer understanding of the challenges and developmental trajectory in pressure ulcer management.